Bio Green Med Solution
BGMS
7 hedge funds and large institutions have $250K invested in Bio Green Med Solution in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 11 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
87% more capital inflows, than outflows
Capital inflows: $241K | Capital outflows: $129K
0.01% less ownership
Funds ownership: 9.31% → 9.3% (-0.01%)
59% less funds holding
Funds holding: 17 → 7 (-10)
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$227K |
| 2 |
Renaissance Technologies
New York
|
+$11.5K |
| 3 |
Tower Research Capital (TRC)
New York
|
+$2.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$30K |
| 3 |
KPP Advisory Services
Louisville,
Kentucky
|
-$10.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$10.7K |
| 5 |
Schonfeld Strategic Advisors
New York
|
-$10.1K |
BGMS Hedge Fund Activity: Q4 2023 in Review
7 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution (BGMS) for Q4 2023, worth a combined $250K — down 39% from $407K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of BGMS and 1 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $227K. The largest seller was Vanguard Group, exiting entirely with an estimated $30.8K sold.
- 7 institutional investors held Bio Green Med Solution (BGMS) as of Q4 2023, down from 17 in Q3 2023.
- Funds reported $250K of Bio Green Med Solution stock for Q4 2023, down 39% quarter-over-quarter.
- 1 fund opened new Bio Green Med Solution positions in Q4 2023 and 11 closed out, a net change of -10 holders.
- The largest Bio Green Med Solution buyer in Q4 2023 was Altium Capital Management, an estimated $227K added.
- The largest Bio Green Med Solution seller in Q4 2023 was Vanguard Group, an estimated $30.8K sold.
Based on aggregated 13F filings for Q4 2023.